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Abbreviations:  30 
ADHD:  Attention-Deficit Hyperactivity Disorder,  31 
BL:   Bright Light,  32 
DSPD:  Delayed Sleep Phase Disorder,  33 
DLMO:  Dim Light Melatonin Onset,  34 
DSWPP: Delayed Sleep-Wake Phase Disorder,  35 
EEG:   Electroencephalogram,  36 
ipRGCs:  Intrinsically Photosensitive Retinal Ganglion Cells,  37 
LT:   Light Therapy,  38 
N24SWD:  Non 24 hour Sleep-Wake Rhythm Disorder,  39 
SAD:   Seasonal Affective Disorder,  40 
SCN:   Suprachiasmatic Nucleus,  41 
SOI:   Sleep Onset Insomnia,  42 
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Abstract: 51 
Objectives. The current paper addresses the evidence for circadian clock characteristics 52 
associated with Attention-Deficit Hyperactivity Disorder (ADHD), and possible therapeutic 53 
approaches based on chronomodulation through bright light therapy. Methods. We review the 54 
data reported in ADHD on genetic risk factors for phase-delayed circadian rhythms and on 55 
the role of photic input in circadian re-alignment. Results. Single nucleotide polymorphisms 56 
(SNPs) in circadian genes were recently associated with core ADHD symptoms, increased 57 
evening-orientation and frequent sleep problems. Additionally, alterations in exposure and 58 
response to photic input may underlie circadian problems in ADHD. Bright light (BL) 59 
therapy was shown to be effective for re-alignment of circadian physiology toward 60 
morningness, reducing sleep disturbances and bringing overall improvement in ADHD 61 
symptoms. The susceptibility of the circadian system to phase shift by timed BL exposure 62 
may have broad cost-effective potential implications for the treatment of ADHD. 63 
Conclusions. We conclude that further research of circadian function in ADHD should focus 64 
on detection of genetic markers (e.g., using human skin fibroblasts) and development of BL-65 
based therapeutic interventions.  66 
 67 
  68 
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Introduction 69 
There is a substantial literature linking dysfunction of the circadian timing system to 70 
the etiology and/or symptomatology of common neuropsychiatric disorders (Foster et al., 71 
2013). Such evidence includes the use of  ex vitro models for the monitoring of circadian 72 
rhythms in gene expression (Brown et al., 2005; Hida et al., 2017), behavioral monitoring 73 
through the use of actigraphy (Ancoli-Israel et al., 2003) and the assessment of other 74 
physiological, endocrine and psychological rhythmic processes (Refinetti, Lissen, & Halberg, 75 
2007). The relevance of the circadian system to neuropsychiatric disorders is further 76 
supported by genetic association studies (Kalman, Garbett, Janka, & Mirnics, 2016). One 77 
such disorder is Attention Deficit Hyperactivity Disorder (ADHD).  78 
Attention-deficit hyperactivity disorder (ADHD) is a neuropsychiatric condition 79 
characterized by inattention and/or hyperactivity-impulsivity that interferes with everyday 80 
functioning (Douglas, 1999; Kaiser, Schoemaker, Albaret, & Geuze, 2014). Based on the 81 
prevailing symptomatology, ADHD has three presentations: (i) predominantly inattentive -, 82 
(ii) predominantly hyperactive– impulsive -, and (iii) combined –(Gaub & Carlson, 1997). 83 
ADHD, although a childhood-onset neurodevelopmental condition, is nevertheless a frequent 84 
and disabling condition in adults (Magnin & Maurs, 2017) due to the relatively high 85 
persistence rates of 40-50% (Lara et al. 2009). The prevalence of ADHD is around 5.3-7% 86 
for children and adolescence, and 3.4-4.4% for adults (Polanczyk et al. 2007, Fayyad et al. 87 
2007, Polanczyk and Rohde 2007). Although the etiology of ADHD remains poorly 88 
understood, ADHD in all age groups has a strong genetic component (Franke et al., 2011).  89 
While attention problems are recognized as a core deficit (Douglas, 1999), deficits in 90 
executive functions (e.g., planning, inhibition and set-shifting) (Pennington & Ozonoff, 91 
1996), motor functioning (Adi-Japha, Fox, & Karni, 2011; Goulardins, Marques, & De 92 
Oliveira, 2017; Kaiser, et al., 2014; Mostofsky et al., 2006), skill learning ("how to" memory) 93 
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(Adi-Japha, et al., 2011; Korman, Levy, & Karni, 2017; Mostofsky, et al., 2006; Nicolson & 94 
Fawcett, 2007), emotional instability (Petrovic & Castellanos, 2016) and sleep problems 95 
(Philipsen, Hornyak, & Riemann, 2006) are recognized as additional key characteristics. 96 
The symptomatology of ADHD may be positively influenced by shifting misaligned 97 
circadian rhythms to more appropriate phase, through pharmacological or behavioural 98 
interventions (Mayer et al., 2018). A successful therapy to influence the circadian rhythm via 99 
changes in the expression of relevant genes, for example, in seasonal depression, is bright 100 
light (BL) therapy, and thus it might be useful for the treatment of ADHD (Kaladchibachi & 101 
Fernandez, 2018; Pail et al., 2011). A recent position paper of physicians and researchers 102 
from the EU has addressed the need to explore and develop light based interventions to 103 
ameliorate ADHD (Coogan, Baird, Popa-Wagner, & Thome, 2016). 104 
 Neurophysiological underpinnings of behavioural manifestations of the ADHD were 105 
linked to brain structures such as the dorsal lateral prefrontal cortex, ventral lateral prefrontal 106 
cortex, insula, anterior cingulate, and dysfunction of dopaminergic systems (Sowell et al., 107 
2003; Tripp & Wickens, 2008). Stimulants, such as methylphenidate, and atomoxetine are 108 
currently the most common pharmacological treatments for ADHD (Chan, Fogler, & 109 
Hammerness, 2016). Appropriate doses of stimulants increasing dopamine’s availability 110 
effectively improve attention, decrease hyperactivity, increase behaviour management and 111 
improve executive functions in individuals with ADHD (Advokat, 2010; Arnsten, 2006; 112 
Rubia et al., 2014; Spencer et al., 2013). Serious adverse events are very rare, but a high 113 
proportion, up to 50%, of stimulant users suffers a range of non-serious adverse events, 114 
which may explain the relatively high withdrawal rates (6-17%) (Storebo et al., 2018). 115 
Moreover, some patients are unresponsive to stimulant medications. Most common non 116 
serious short-term and long-term adverse effects include insomnia and other sleep problems, 117 
headache, abdominal pain and poor appetite (Graham & Coghill, 2008; Storebo, et al., 2018). 118 
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Non-stimulants, such as atomoxetine may affect cardiovascular parameters, but do not affect 119 
sleep (Graham & Coghill, 2008). These recently reported numbers call to investigate what is 120 
the cost of such “non-serious” but chronic sleep problems and meal mis-timings due to 121 
medications. How these problems are related to the inherent, treatment independent problems 122 
with sleep and late chronotype in significant proportion of ADHD patients across the lifespan 123 
(Coogan & McGowan, 2017)?  124 
In the current review we aim underscore the importance of continuing the search for 125 
biological markers of ADHD and incorporation of non-pharmacological modalities in 126 
treatment protocols utilizing chronobiological perspective on ADHD etiology. We 127 
hypothesize that patients with ADHD are candidates for a novel clinical approach that 128 
includes a confirmatory laboratory evaluation, incorporating clock gene-based diagnosis and 129 
circadian behavioural and biomarker’s testing. We propose that the use of Light Therapy 130 
(LT) has a potential to induce short-term and long-term improvements in cognitive, 131 
behavioural and emotional measures in patients with ADHD. Our review suggests a potential 132 
directive in encouraging research to 1) determine the benefits of coupling fibroblasts’ genes 133 
expression phase markers with cognitive (e.g., reaction time) and physiological markers (e.g., 134 
melatonin, cortisol) as a multi-dimensional diagnostic method of circadian dysregulation in 135 
ADHD; 2) evaluating whether appropriately timed LT is a potent sleep, cognitive and 136 
emotional enhancer in ADHD, either directly or mediated via circadian phase shifting. In 137 
particular, of interest are the differential effects of three principally different light protocols 138 
(natural light, blue light and dawn-like gradually changing light) on the short- and long-term 139 
cognitive and emotional functional outcomes; and 3) evaluating, through randomized, 140 
placebo-controlled studies, the relative effectiveness of light therapy compared to standard 141 
pharmacological therapy to treat ADHD symptoms. We conclude that LT interventions that 142 
independently or in conjunction with pharmacological treatment may improve core 143 
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symptomatology of ADHD or compensate for common adverse effect of stimulant 144 
medications, primarily, sleep insufficiency, is of highest clinical importance. Moreover, LT 145 
has the potential for augmentation or even prevention of psychiatric comorbidities in adult 146 
ADHD, such as sleep and mood disorders. 147 
The review starts with an overview of sleep and circadian rhythm dysfunction in 148 
ADHD. Next, we describe the maintenance of the circadian timekeeping system “by” clock 149 
genes, and its modulation by photic input. Recent findings unveiling the connection between 150 
the circadian function and clock genes in different psychiatric disorders and in ADHD, 151 
including the fibroblasts model, are summarized in the core part of the paper. In the 152 
concluding section, light therapy for circadian alignment in ADHD and future directions of 153 
integrated research, diagnosis and treatment are discussed. 154 
ADHD, sleep and circadian rhythm dysfunction 155 
ADHD in adolescents and adults is associated with the evening chronotype (Baird, 156 
Coogan, Siddiqui, Donev, & Thome, 2012; Bumb et al., 2016; Coogan & McGowan, 2017; 157 
Vogel et al., 2017), with ADHD individuals displaying preference for late sleep timing and, 158 
accordingly, late timing of awakening. While more than 40% of adults with ADHD display 159 
an evening preference, only about 11% of age-matched healthy peers show this preference 160 
(Rybak, McNeely, Mackenzie, Jain, & Levitan, 2007). Greater eveningness is associated with 161 
shorter night sleep periods. Consequently, a sleep debt may play a causal role in the core 162 
symptoms of inattention and increased impulsivity (Rybak, et al., 2007). The hyperactivity of 163 
ADHD patients is expressed in greater motility at night-time and may lead to sleep 164 
deprivation (Philipsen, 2006). Also, seasonal affective disorder (SAD), a type of depression 165 
disorder directly linked to circadian disruption, shows high comorbidity with ADHD 166 
(Wynchank et al., 2016). The core symptoms of ADHD, such as inattention, impulsivity and 167 
impatience, are typical outcomes of sleep deprivation even in typical adults (Corkum, 168 
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Tannock, & Moldofsky, 1998). As many as 70% of children and up to 83% of adults with 169 
ADHD have been reported as having sleep problems (Philipsen, et al., 2006) with sleep onset 170 
insomnia (SOI) being the most common problem (Van der Heijden, Smits, Van Someren, & 171 
Gunning, 2005). Adults with ADHD also report reduced sleep quality, meaning difficulties in 172 
falling asleep and in waking up (Kooij & Bijlenga, 2013). More than 60% of adults with 173 
ADHD report increased sleepiness during day-time (Kooij & Bijlenga, 2013; Van der 174 
Heijden, et al., 2005; Van Veen, Kooij, Boonstra, Gordijn, & Van Someren, 2010). 175 
Interestingly, neurobiological delayed timing of melatonin secretion is found in children and 176 
adults with ADHD (Van der Heijden, et al., 2005; Van Veen, et al., 2010). Sleep problems 177 
and ADHD seem to interact in a complex bidirectional manner with sleep disturbances 178 
exacerbating ADHD symptoms and ADHD symptoms exacerbating sleep disturbances 179 
(Owens et al., 2013). In normally developed adults, sleep after practicing a new motor skill, 180 
supports memory consolidation processes, contributing to the generation of stable, enhanced 181 
and long lasting procedural memory representations (Debas et al., 2010; Korman, Raz, Flash, 182 
& Karni, 2003), but when applying the protocols developed for normally developed controls 183 
to adults with ADHD, overnight motor memory consolidation is hampered (Adi-Japha, et al., 184 
2011; Fox, Karni, & Adi-Japha, 2016; Korman, et al., 2017).  185 
ADHD is also associated with disrupted regulation of arousal during wake (Brennan 186 
& Arnsten, 2008; Hegerl & Hensch, 2014). Arousal is the physiological and psychological 187 
state of being awoken or of sense organs stimulated to a point of perception (Schachter, 188 
1964). Individuals with ADHD tend to be under-aroused in “normal” performance and 189 
learning conditions (James, Cheung, Rijsdijk, Asherson, & Kuntsi, 2016; Wainstein et al., 190 
2017; Zentall & Zentall, 1983). An optimal arousal level is considered a prerequisite for 191 
successful cognition functioning (Yerkes & Dodson, 1908; Zentall & Zentall, 1983). 192 
Cognitive theories of ADHD, such as the state regulation model (van der Meere, 2005) and 193 
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dual-process models (Halperin & Schulz, 2006; Johnson et al., 2007) propose that the high 194 
within-subject fluctuations of cognitive performance in ADHD may reflect problems in 195 
regulating arousal. Unstable and low arousal results in the inability or difficulty to sustain 196 
attention on any task of waning novelty (Sikstrom & Soderlund, 2007; Strauss et al., 2018). 197 
Resting EEG parameters of arousal level (Strauss, et al., 2018) and arousal stability (Sander, 198 
Arns, Olbrich, & Hegerl, 2010; Strauss, et al., 2018) were recently suggested as biomarkers 199 
for adult and paediatric ADHD. The restless behaviour of individuals with ADHD during 200 
wake is interpreted as self-stimulation in order to raise their arousal level (Baijot et al., 2016; 201 
Strauss, et al., 2018) and, consequently, performance. Altogether, altered circadian 202 
functioning is associated with ADHD (Coogan & McGowan, 2017), suggesting that inner, 203 
biological time-keeping malfunction may be an important factor in this clinical condition. 204 
The circadian timekeeping system is generated by “clock” genes 205 
The circadian timekeeping system underpins the generation of near 24-hour rhythms 206 
of variations in physiology and behavior. These cycles are not a response to the changes in 207 
the light or temperature around us: they are genetically encoded in a cell-autonomous 208 
manner, and at a systems level the circadian timekeeping is the result of a hierarchical, highly 209 
distributed whole organism system (Albrecht, 2012). The circadian clock cycle continues 210 
running, in the absence of periodic environmental stimuli, to best synchronize physiology and 211 
behavior, and with reference to the external environment, to the earth’s rotation (Duffy, 212 
Rimmer, & Czeisler, 2001). However, the circadian clock can only reliably fulfil its function 213 
in a constantly changing environment if it is synchronized (“entrained”) to appropriate 214 
temporal cues in the environment. For mammals, the most important entraining stimulus 215 
(“zeitgeber”) is light (Hughes, Jagannath, Hankins, Foster, & Peirson, 2015). Other non-216 
photic day time events, such as meal timing and social cues may also serve as zeitgebers, 217 
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although under normal circumstances light is setting circadian phase (Roenneberg & Merrow, 218 
2016). 219 
The master circadian clock is located in the suprachiasmatic nucleus (SCN) of the 220 
hypothalamus (Moore, 1997; Reppert & Weaver, 2002). The SCN comprises a cell-221 
autonomous oscillatory network of synchronized individual clock neurons, which projects its 222 
rhythm onto cell-autonomous clocks throughout the brain and peripheral tissues (Welsh, 223 
Takahashi, & Kay, 2010). A subset of SCN neurons are stimulated by photic input 224 
transmitted via the retinohypothalamic tract. The retinal receptors (intrinsically 225 
photosensitive retinal ganglion cells (ipRGCs)) are specialized cells independent of the visual 226 
system. The signal is monosynaptical propagated using glutamate as a transmitter. This 227 
results in activation of the retinal receptors through modulating the electrophysiological 228 
properties. (Welsh, et al., 2010). Moreover, SCN neurones display circadian rhythms in their 229 
electrophysiological properties, and these electrophysiological rhythms are underpinned by 230 
circadian clock genes (Belle, Diekman, Forger, & Piggins, 2009). At the molecular level, 231 
circadian rhythms are generated via feedback loops involving a panel of clock genes and their 232 
protein products (Albrecht, 2012). 233 
At the molecular level, circadian rhythms are generated via feedback loops involving 234 
a panel of clock genes and their protein products (Albrecht, 2012). The most important 235 
circadian genes include circadian-locomotor output-cycle kaput-genes (Clock), brain and 236 
muscle-Arnt-like 1 gene (Bmal1), periodic homolog genes (Per1/2/3) and cryptochrome 237 
genes (Cry1/2) (Sato et al., 2006). The transcription factors CLOCK and BMAL1 238 
heterodimerize and consequently bind to the promotor region of PER and CRY resulting in 239 
activation of these genes. After translation and transcription, PER and CRY proteins are 240 
gradually stabilized during the day and inhibit the activity of CLOCK and BMAL1. The 241 
result of this negative feedback loop is the inhibition in the expression of PER and CRY (Lee, 242 
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Etchegaray, Cagampang, Loudon, & Reppert, 2001; Shearman et al., 2000). After 24 hours 243 
one cycle is finished and the process starts again. CLOCK and BMAL1 are not only involved 244 
in the activation of PER and CRY. Both activate clock-controlled genes in different 245 
peripheral tissues (Janich et al., 2011; Marcheva et al., 2010; Paschos et al., 2012). This 246 
circadian clock gene cycle has a widespread influence on the transcriptome, with 40% of all 247 
mammalian genes showing circadian rhythms in their expression in at least one tissue 248 
(Zhang, Lahens, Ballance, Hughes, & Hogenesch, 2014). 249 
The SCN is rather a “master synchronizer” than a pacemaker. Most tissues show 250 
circadian patterns of gene expression when cultured, although such rhythms dampen over a 251 
number of days (Buhr & Takahashi, 2013). The SCN communicates with peripheral clocks 252 
over several pathways, including hormonal cues (glucocorticoids, melatonin) and indirect 253 
cues (body temperature, food intake; (Panda, 2016)). Each cue can phase-shift a peripheral 254 
oscillator but may not alter the phase of the central clock, potentially leading to an internal 255 
desynchrony of the circadian system, which in turn may lead to adverse outcomes 256 
(Roenneberg & Merrow, 2016).  257 
Chronotype, Clock genes and ADHD 258 
One interesting pivot-point for the examination of genetic factors that may link 259 
ADHD and circadian clocks is chronotype. Chronotype is usually measured as the 260 
manifestation of preferred or actual timing of sleep/wake behaviour, and is shaped by 261 
ontological, environmental and genetic factors (Adan et al, 2013). Later chronotype 262 
(eveningness) is characterised by a later phase of entrainment of the endogenous circadian 263 
system to environmental time cues resulting in later self-selected timing of sleep onsets and 264 
offset, and morning types display an earlier phase of entrainment and converse effects on 265 
sleep timing (Roenneberg et al, 2003). Chronotype may also be shaped by inter-individual 266 
differences in sleep homeostasis, and as such should not be viewed as a purely circadian 267 
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phenomenon (Mongrain et al, 2006). Later chronotype is associated with a number of 268 
psychopathological features in both clinical and non-clinical populations (Antypa et al, 2017; 269 
Lemoine et al, 2017; Hsu et al, 2012). Chronotype has also been shown to influence a broad 270 
range of cognitive functions, including the ADHD-relevant domains of attention 271 
(eveningness associated with more inattention; Hennig et al, 2017) and impulsivity and risk-272 
taking (eveningness associated with more impulsive behaviours; McGowan et al, 2016; Ponzi 273 
et al, 2014).  The relative advantage of assessing chronotype over other circadian parameters 274 
is that it can be reliably measured using validated questionnaires, and as such is more 275 
scaleable than other approaches such as actigraphy or physiological and molecular measures 276 
(Adan et al, 2012). 277 
As mentioned previously, ADHD is associated with late chronotype, possibly 278 
indicating a later entrained phase of the clock, altered sleep homeostasis, or an interaction 279 
between the two (Coogan & McGowan, 2017). Similar to  other behavioural traits, 280 
chronotype is found be to be heritable, with reported rates of heritability from family and 281 
twin-studies in the range of 21% (Evans et al, 2011) to 40-50% (von Schantz et al, 2015; 282 
Barclay et al, 2010).  The putative genetic basis of chronotype has recently been explored in a 283 
number of genome-wide association studies.  Lane and colleagues (Lane et al., 2016) report 284 
12 loci significant at the genome-wide level that are associated with chronotype in the UK 285 
Biobank sample, including loci with previously described roles in the clock (PER2, an ASPS 286 
gene, APH1A, RGS16 and FBXL13). These 12 loci accounted for 4.3% of the variance in the 287 
extremities of chronotype, which in the UK BioBank is assessed by a single Likert 5 choice 288 
self-assessment of diurnal preference (from the question “Do you consider yourself to be…” 289 
and answers ranging from “Definitely a morning person” to “Definitely an evening person”). 290 
A further study on the UK BioBank cohort reported 16 significant loci associated with 291 
morningness, including ones near PER2 and RGS16 which is involved in phototransduction  292 
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(Jones et al., 2016). Hu and colleagues (Hu et al., 2016) report 15 loci associated with 293 
morningness (assessed with two question parsed into a binary morning or evening responses 294 
in the 23 and Me cohort), including 7 loci near genes with known circadian roles such as 295 
those encoding vasoactive intestinal polypeptide (VIP), PER3, FBXL3 and hypocretin 296 
receptor 2. Across these three studies, 9 loci were common in at least two studies, indicating 297 
that genetic factors are important in shaping chronotype and that GWAS approaches are 298 
insightful for this question  (Kalmbach et al., 2017). Interestingly, a recent study has shown 299 
overlap between genetic predisposition for eveningness and bipolar disorder (Melroy-Greif, 300 
Gizer, Wilhelmsen, & Ehlers, 2017). Importantly, another recent study using umbilical 301 
fibroblast have shown that factors associated with protein turnover are associated with 302 
chronotype, indicating that circadian clock-non-specific factors may be important in 303 
influencing clock dynamics and shaping chronotype (Gaspar et al., 2017). 304 
Two of the GWAS analyses of the genetic architecture of chronotype also examined 305 
genetic overlap between chronotype and ADHD: Lane et al (2016) reported no significant 306 
genetic associations for chronotype with genetic risk for ADHD, and Jones et al (2016) 307 
reported a similar null finding. Interestingly both studies do report significant associations for 308 
the genetic risk scores for chronotype with those for schizophrenia. There are a number of 309 
potential reasons for such observations. Firstly, the variance in chronotype accounted for by 310 
the identified loci is modest (~4%, Lane et al, 2016), and chronotype is seemingly at most 311 
50% heritable (von Schantz et al, 2015); as such the later chronotype reported in ADHD may 312 
be behaviourally and environmental determined to a greater extent than genetically so. Such 313 
an interpretation would situate phase-delays/later chronotype associated with ADHD more as 314 
“egg” (i.e. results of other ADHD features) rather than as “chicken” (i.e. causal genetic 315 
relationship from circadian to ADHD features). As such, delayed circadian phase as might be 316 
indicated by later chronotype may provide a target for behavioural therapies designed to 317 
14 
 
counteract these phase shifts and ultimately to alleviate ADHD symptoms (see section 3).  318 
Clock gene polymorphisms may not confer increased stand-alone genetic risk for ADHD 319 
diagnosis, but may confer increased risk for ADHD symptom severity in interaction with 320 
environmental factors; a recent report utilising random forest regression reported a significant 321 
effect of PER3 in interaction with stress in predicting ADHD severity (van der Meer et al., 322 
2017). Another important caveat is that GWAS studies do not detect rare variants with a 323 
minor allele frequency of <5% (Kalmbach et al, 2017). As such, rare variants that have been 324 
reported to exert large effects on chronotype would not be captured in such analyses (Jones et 325 
al, 1999; Patke et al, 2017). Targeted, hypothesis-driven genetic analysis may reveal roles for 326 
such rare variants in ADHD. The final caveat in relation to GWAS studies of chronotype to 327 
date is that circadian phenotyping has been based on only one or two questions generating 328 
categorical scores based on diurnal preference, there is clear potential for loss of statistical 329 
power and granularity in assessing subtleties of circadian phenotype that would not be 330 
captured in such approaches (Kalmbach et al, 2017). 331 
There are a number of older studies utilising analysis of single gene polymorphisms in 332 
clock genes in ADHD samples. Whilst such studies have many well documented weaknesses, 333 
including lack of statistical power, failure to account for epistasis and failure to replicate 334 
(Farrell et al., 2015), it is interesting to note that specific polymorphisms in circadian genes 335 
may result in very strong phenotypes. For example, an uncommon (allele frequency of ~0.1 336 
to 0.6%) SNP in CRY1 leads to a gain-of-function mutation that results in a larger phase 337 
delay of the rest/activity cycle that manifests as delayed sleep phase disorder (Patke et al., 338 
2017).  A C/T SNP in the 3’-untranslated region of CLOCK rs1801260 was suggested to be 339 
associated with chronotype in a candidate gene study (Katzenberg et al., 1998) (although see 340 
(Iwase et al., 2002; Johansson et al., 2003; Pedrazzoli et al., 2007), and was subsequently 341 
examined in adult ADHD. Kissling et al (2008) report that the T allele was a risk factor for 342 
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ADHD psychopathology in adults (Kissling et al., 2008). Xu and colleagues examined the 343 
same SNP in adult ADHD and reported that the allele was overtransmitted in ADHD (Xu et 344 
al., 2010). C allele in this SNP in CLOCK was also associated with ADHD symptoms in the 345 
general population. This association was not mediated through chronotype (Jeong et al., 346 
2014). Of particular interest for these studies is a report that the rs1801260 SNP in CLOCK is 347 
associated with altered CLOCK transcript stability and altered CLOCK protein expression; 348 
therefore this is likely to be a functional mutation that alters the dynamics of the clock gene 349 
cycle and circadian physiology (Shi et al., 2008).  350 
Another clock gene polymorphism that has received considerable interest is the 4/5 351 
variable number tandem repeat (VNTR) polymorphism in PER3 (Dijk & Archer, 2010). This 352 
VNTR has been associated with chronotype, sleep homeostasis and various psychiatric 353 
disorders (Archer et al., 2010). The VNTR in PER3 has been associated with difference in 354 
executive function (planning performance assayed by the Tower-of-London task; (González-355 
Giraldo et al., 2015)). Further, a SNP in PER3 has recently been linked with ADHD in adults 356 
(van der Meer, et al., 2017). As such, PER3 may represent an interesting locus for future 357 
study in the genetic overlap between circadian function and ADHD. Other promising 358 
associations with clock genes that may be pertinent to ADHD include an association with a 359 
SNP in PER2 with reward in healthy adolescents (Forbes et al., 2012) and a SNP in PER1 360 
predicting problematic alcohol use (Baranger et al., 2016). Future work will hopefully 361 
address further the genetic overlap between the circadian system and ADHD, in order to 362 
better understand the nature of the links between circadian timing and ADHD, and to offer 363 
new targets for experimental monitoring and even therapeutic targeting. 364 
The behavioural role of clock genes can be studied using reverse genetic approaches 365 
in animal models, in which candidate genes are knocked out or altered (Merrow, Spoelstra, & 366 
Roenneberg, 2005). A number of clock gene knockout animals show hyperactivity as part of 367 
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their behavioural phenotype, as well as various cognitive alterations. Mice carrying the 368 
dominant negative CLOCK mutation show mania-like behaviour, including hyperactivity, 369 
decreased sleep, lowered depression-like behaviour, reduced anxiety and an increased reward 370 
value in association with elevated dopaminergic activities in the central tegmental area 371 
(McClung et al., 2005; Roybal et al., 2007). However, this line of inquiry is complicated by 372 
the lack of well validated animal models of ADHD, and the fact that hyperactivity as 373 
observed in many models may be a highly non-specific phenotype and not particularly 374 
relevant to ADHD-related processes (Carvalho, Vieira Crespo, Ferreira Bastos, Knight, & 375 
Vicente, 2016). 376 
A challenge in all studies of circadian function in humans is which, and how many, 377 
phase biomarkers can and should be examined (Roenneberg & Merrow, 2016). Given that 378 
SCN, and other central tissue, cannot be accessed in such studies as one would in animal 379 
studies, investigators seek to assay peripheral oscillators that can be reasonably sampled. One 380 
method is to measure circadian differences within and between populations in tissue biopsies 381 
yielding primary skin fibroblasts. Individual circadian characteristics are manifested in both 382 
central and peripheral oscillators (Brown, et al., 2005), and as such skin fibroblasts may serve 383 
as useful substrate for the analysis of molecular circadian function. In fibroblasts transfected 384 
with a bmal1::luciferase reporter, period length is influenced by culture conditions (e.g. 385 
temperature, concentration of serum in growth medium), but cells displaying short- and long-386 
period lengths retain their relative values under all conditions and period length is also 387 
associated with chronotype (Brown, et al., 2005). Alterations in per2::luc rhythms have also 388 
been reported in fibroblasts derived from patients with bipolar disorder, and these factors 389 
predict responses to lithium (McCarthy et al., 2013). Recently, a study by Hida et al., showed 390 
that an in vitro fibroblast rhythm assay accurately describes circadian behaviour of patients 391 
with two types of circadian rhythm sleep disorders - delayed sleep-wake phase disorder 392 
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(DSWPD) and non-24-hour sleep–wake rhythm disorder (N24SWD) (Hida, et al., 2017). 393 
Patients in this study received a four week chronotherapy (bright light therapy + 394 
melatonin/melatonin receptor agonist administration). Longer in vitro period predicted poorer 395 
response to chronotherapy in patients with N24SWD (Hida, et al., 2017). This and additional 396 
studies (Vanselow et al., 2006), suggest that in vitro fibroblasts rhythm assays may provide a 397 
valid tool to assess individual genetic characteristics in the biological clock of different 398 
populations. Moreover, multiple pre- post- treatment fibroblast samples may contribute to the 399 
evaluation of the efficacy of the phase-shifting treatments, including LT and melatonin 400 
administration. To our best knowledge, there are no studies reporting usage of fibroblast 401 
assays in ADHD diagnosis; given previous indications of clock gene expression changes in 402 
ADHD (Baird, et al., 2012) such approaches may yield important insight into the alterations 403 
of circadian processes at the molecular level in ADHD. 404 
Cyclic production of pineal melatonin, released by the pineal gland in the absence of 405 
blue light via the sympathetic system, informs the clock about photoperiod (e.g., day 406 
length)(Stehle, von Gall, & Korf, 2003). As the sympathetic drive to the pineal is gated 407 
through the SCN, the time of onset of melatonin biosynthesis under dim light conditions is a 408 
very useful phase-marker (Keijzer, Smits, Duffy, & Curfs, 2014). Melatonin may play an 409 
important role in the rhythmic clock gene expression (CLOCK, BMAL1, PER1-3, CRY1-2) 410 
(Dardente et al., 2003; von Gall et al., 2005), and in various neurological functions and stress 411 
response (Hardeland, Madrid, Tan, & Reiter, 2012). Exogenous melatonin and 412 
melatoninergic agonists are shown to entrain the sleep-wake cycle, advance endogenous 413 
melatonin secretion and enhance total time asleep in children with ADHD and chronic sleep 414 
onset insomnia (Chamorro, Lara, Insa, Espadas, & Alda-Diez, 2017; Van der Heijden, Smits, 415 
Van Someren, Ridderinkhof, & Gunning, 2007). Further, adults with ADHD with chronic 416 
sleep onset insomnia show delayed onset of melatonin secretion (Bijlenga et al., 2013; Van 417 
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Veen, et al., 2010), indicating a delayed phase in a SCN-derived signal. Other rhythmic 418 
endocrine signals also show alterations in ADHD; cortisol, which shows a strong 24 rhythm 419 
driven by the SCN, shows a phase-delay relative to wake-time in adult ADHD (Baird, et al., 420 
2012), and changes in the diurnal cortisol profiles have been linked with alterations in arousal 421 
levels in children with ADHD (Imeraj et al., 2012). Therefore, assessment of rhythmic 422 
endocrine function in ADHD, and its relationship to ADHD symptom severity and ADHD 423 
medication, represents an important substrate for future investigation.  424 
Light treatment for circadian alignment 425 
Light is the primary synchronizer of the circadian timing system (Hughes, et al., 426 
2015). Visible light has a wavelength spectrum of 380 (violet) to 760 (red) nm. The intensity 427 
of sunlight, depending on geographical location and season of the year, range between 7,000-428 
100,000 lux (Roenneberg, Kantermann, Juda, Vetter, & Allebrandt, 2013). The effects of 429 
timing (Czeisler et al., 1986), duration (Chang et al., 2012), intensity (Boivin, Duffy, 430 
Kronauer, & Czeisler, 1996) and wavelength (Revell, Arendt, Terman, & Skene, 2005) of 431 
light stimuli on the human sleep-wake cycle are well established in a variety of measures, 432 
including phase resetting and the suppression of the sleep promoting hormone, melatonin 433 
(Chellappa, Gordijn, & Cajochen, 2011). The light-induced entraining is mediated via 434 
intrinsically photosensitive retinal ganglion cells (ipRGCs) that project to the SCN in the 435 
hypothalamus. The ipRGCs contain melanopsin, an opsin-like protein, most sensitive to blue 436 
light (the shortest wavelength of the visual spectrum) (Hankins, Peirson, & Foster, 2008). 437 
However, ipRGC light response is a composite one, influenced by both the extrinsic 438 
(rod/cone) and the intrinsic (melanopsin) activation and ipRGC may play a role in visual 439 
image formation (Allen, Storchi, Martial, Bedford, & Lucas, 2017). Light, via response of 440 
ipRGCs to its spectral properties and intensity, induces a variety of non-visual responses, e.g., 441 
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raising alertness, pupil constriction and suppression of pineal hormone melatonin release 442 
(Debra & Josephine, 2006).  443 
Thus, short wavelength blue light (460 nm) possesses greater phase shifting potential 444 
than the rest of the visible light spectrum (Lockley et al., 2003, Warman et al., 2003, Wright 445 
et al., 2004). Currently, there are no standardized guidelines for the application of light 446 
therapy. Based on laboratory and field studies, light therapy should be sufficiently bright 447 
(2,000-10,000 lux) to elicit a clinically significant response and should last long enough (>30 448 
min) (van Maanen, Meijer, van der Heijden, & Oort, 2016). Blue light as an environmental 449 
factor has been shown to be toxic to rod photoreceptors when the retina is exposed to either 450 
high light intensities or to continuous light over a long period of time (Lack, Bramwell, 451 
Wright, & Kemp, 2007; Youssef, Sheibani, & Albert, 2011). Therefore, long-term users of 452 
bright light therapy lamps should be screened by ophthalmologists, and those with pre-453 
existing retinal conditions or other risk factors should abstain from bright light (BL) therapy 454 
(Youssef, et al., 2011).  455 
Natural daylight is considered the strongest zeitgeber for the circadian clock (Wright 456 
et al., 2013). Effects of daylight are different from the artificial light and, in particular, BL 457 
used in traditional light treatments, in several aspects. (i) In nature, dark-light transitions are 458 
always gradual, giving biological systems time to adjust; graduate light exposure has been 459 
shown to be an important factor in the photic entrainment of the biological clock (Endo, 460 
Kripke, & Ancoli-Israel, 2015; Grandner, Kripke, Elliott, & Cole, 2013). Light-detecting 461 
neurons in the circadian system have response characteristics suitable for detection of slow 462 
changes in light intensity and spectrum during twilight (Endo, et al., 2015; Grandner, et al., 463 
2013; Usui, 2000). Exposure to BL, even through closed eyelids, was shown to be effective 464 
for melatonin suppression (Figueiro, Plitnick, & Rea, 2014; Terman & Terman, 2006). 465 
Studies that examined rhythm-entraining properties of artificial twilight and fluctuating light 466 
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intensity cycles, underscored the importance of gradual transition between light and darkness 467 
for circadian rhythm entrainment in animal models and humans (Avery et al., 2001; Boulos, 468 
Macchi, & Terman, 2002; Usui, 2000; Van De Werken et al., 2010). (ii) Colour (spectral) 469 
qualities of natural daylight are rich and dynamically changing, while properties of BL used 470 
in therapy protocols and in ambient artificial lighting are usually invariable and thus 471 
biologically insufficient (Beute & de Kort, 2014; Hye Oh, Ji Yang, & Rag Do, 2014; Terman 472 
& Terman, 1999). (iii) Cumulative amount of light during the day impacts human circadian 473 
behavior - geographically defined amount of solar irradiation is linked to distributions of 474 
chronotypes in population, with living at higher-latitudes areas predisposes to eveningness 475 
(Leocadio-Miguel et al., 2017). In line with the latter, lower prevalence of ADHD was 476 
recently associated with geographic areas of higher solar intensities  (Arns, van der Heijden, 477 
Arnold, & Kenemans, 2013). In general, modern people spend increasingly more time 478 
indoors, where ambient light is orders of magnitude lower in intensity compared to outdoor 479 
light on a clear day (Roenneberg, et al., 2013). Despite the importance of daylight for human 480 
wellness and functionality, the neuropsychological consequences of exposure to natural light 481 
in comparison to interventions using artificial light are currently poorly understood and the 482 
potential of exposure to daylight has not been systematically evaluated both in healthy and 483 
clinical populations. Thus, the mainstream of light treatment engages protocols of exposure to 484 
artificially generated BL (Terman & Terman, 1999). 485 
The susceptibility of the circadian clock to be shifted by time-specific light exposure 486 
is thoroughly studied and is broadly utilized in treatment protocols of sleep-phase and 487 
depressive disorders, e.g., SAD (Gooley, 2008; Kaladchibachi & Fernandez, 2018; Oldham 488 
& Ciraulo, 2014). Long-term light interventions effectively advance sleep onset time (van 489 
Maanen, et al., 2016; Watanabe, Kajimura, Kato, Sekimoto, & Takahashi, 1999) as well as 490 
result in less sleepiness after awakening in neurotypical adults with DSPD (Lack, et al., 2007; 491 
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Van De Werken, et al., 2010), for a review see (Figueiro, 2016). Wu et al. (2009) treated 492 
patients with bipolar disorder with three interventions: sleep deprivation, BL and sleep phase 493 
advance. All three non-invasive interventions result in depression decrease (Wu et al., 2009). 494 
A study with patients suffering from non-seasonal major depressive disorder observed a 495 
positive effect of BL therapy, too. Treatment with BL, either as monotherapy or combined 496 
with medication (fluoxetine) showed a consistent effect (Lam, Levitt, Levitan, & et al., 497 
2016). Simulated dawn was proposed as an adjunct and even alternative to BL therapy or 498 
medication in the treatment of SAD (Avery, et al., 2001; Terman & Terman, 2006). In 499 
addition to easing compliance, naturalistic dawn simulation eliminates possible ocular 500 
adverse effects due to exposure to high intensity blue light of conventional BLT protocols 501 
(Terman & Terman, 1999). 502 
One inherent problem of bright light studies is the choice of an appropriate placebo 503 
condition (Eastman, Young, Fogg, Liu, & Meaden, 1998). Several types of placebo or a 504 
combination of them are used in placebo-controlled LT studies: dim red light (as opposed to 505 
bright blue light), differently timed light (evening vs. morning), an inert placebo (a light box 506 
emitting no visible light) or an inert (deactivated) negative ion generator (for examples see 507 
(Chojnacka et al., 2016; Eastman, et al., 1998; Sit et al., 2018)). Indeed, due to the lack of an 508 
obvious type of placebo treatment, LT studies have been extensively criticized for their 509 
flawed experimental design. And yet, at least for the treatment of seasonal and non-seasonal 510 
depression, an accumulated bulk of randomized and double-blind clinical trials approves the 511 
utility of LT and invites further studies in other psychiatric, neurodevelopmental and 512 
neurocognitive disorders (for review see (Kaladchibachi & Fernandez, 2018)). 513 
Most patients with ADHD demonstrate delays in sleep-wake rhythms and 514 
irregularities in melatonin and cortisol production times compared to healthy controls. 515 
Considering the fact that ADHD has high co-morbidity with depression (Amons, Kooij, 516 
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Haffmans, Hoffman, & Hoencamp, 2006; Turgay & Ansari, 2006), is strongly associated 517 
with delayed sleep phase syndrome (Amons, et al., 2006; Baird, et al., 2012; Coogan & 518 
McGowan, 2017; Turgay & Ansari, 2006), and given an association between ADHD 519 
prevalence and solar intensity at geographic loci (Arns, et al., 2013), the body of literature on 520 
the effects of light therapy in ADHD is currently very limited. 521 
A three-week trial of light therapy (LT) to a group of 29 adults with ADHD (Rybak, 522 
McNeely, Mackenzie, Jain, & Levitan, 2006) used a full-spectrum fluorescent light box that 523 
emitted 10,000 lux, for half an hour each morning, showed that morning BL therapy did help 524 
alleviate subjective reports of deficits in maintaining effort and arousal, while improving 525 
problems with inattention. Furthermore, neuropsychological testing further confirmed that LT 526 
produced significant improvements on attentional functioning which was shown in basic 527 
auditory attention span as well as for 2 key components of the Conner’s' Continuous 528 
Performance Test (CPT-II), indicating improvements in impulsivity and behavioural 529 
inhibition. Circadian shift towards morningness was shown in many of the participants 530 
(Rybak, et al., 2006). 531 
A two-weeks LT in the morning (30-min morning 10,000 lux exposure 3h after mid-532 
sleep time) in pharmacologically treated participants with ADHD (with different, individually 533 
prescribed drugs) significantly advanced the phase of dim light melatonin onset (DLMO) and 534 
mid-sleep time (Fargason et al., 2017). These phase advances correlated with decreased total 535 
scores in ADHD rating scales as well as hyperactivity-impulsivity indices (Fargason, et al., 536 
2017). Even a single week of LT (1h at 9:00 AM, 2500 lux) in adolescents with ADHD, who 537 
were medicated (40 mg Methylphenidate daily) and engaged in psychotherapy, was 538 
successful (Niederhofer, 2013). Behavioural improvements were found in both for the 539 
Conner’s inattention score and in the hyperactivity score. Moreover,  evening melatonin 540 
levels increased post-treatment (Niederhofer, 2013). 541 
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Compared to the long-term effects of light on human circadian rhythms, little 542 
attention has been paid to its acute alerting action. High intensity light exposure acutely 543 
reduces subjective sleepiness, improves well-being and neurobehavioral performance, 544 
reduces attentional lapses, and activates the waking electroencephalogram (EEG) (Badia, 545 
Myers, Boecker, Culpepper, & Harsh, 1991; Beute & de Kort, 2014). These alerting effects 546 
appear to be dose dependent, such that higher illuminances have greater immediate effects 547 
(Cajochen, Zeitzer, Czeisler, & Dijk, 2000). Significant advance of DLMO was shown 548 
following a single morning exposure to BL during morning hours (>3000 lux) (Kozaki, Toda, 549 
Noguchi, & Yasukouchi, 2011).  550 
Surprisingly, light as acute alerting agent was not clinically studied in ADHD. We 551 
hypothesize that exposure to BL in ADHD may produce effects similar to other types of 552 
sensory stimulation during wakefulness. Various types of extra-task sensory stimulations 553 
were reported beneficial for cognitive performance of children with ADHD, e.g., background 554 
linguistic noise during a reading/arithmetic task (Zentall & Shaw, 1980), pictures during a 555 
continuous performance auditory task (Zentall & Meyer, 1987), background music during 556 
arithmetic tasks (Abikoff, Courtney, Szeibel, & Koplewicz, 1996) and auditory white noise 557 
during a visually cued Go/NoGo task (Baijot, et al., 2016). If sensory stimulation in one or 558 
more forms may enhance cognitive functioning of people with ADHD, similar acute effects 559 
may be found for light treatment, especially given that light positively affects attention and 560 
performance in neurotypical adults (Beute & de Kort, 2014). 561 
It has been previously suggested that core cognitive processes, such as memory 562 
consolidation, are extant but under-engaged in adults with ADHD and that this potential can 563 
be unveiled in specific bio-behavioural conditions, contingent on the individual’s chronotype 564 
(Korman, et al., 2017), - e.g., by scheduling of training session to evening. A different, 565 
chronotherapy approach by appropriately timed LT, may eliminate the need to adapt 566 
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conditions of training and performance to chronotype by long-term phase advancement of the 567 
clock. LT is associated with dopaminergic (Kim et al., 2017), adrenergic (Bowrey, James, & 568 
Aston-Jones, 2017) and serotonergic (Li, 2018) brain circuits activation, pathways directly 569 
associated with learning, executive functioning and mood. The SCN’s endogenous ∼24h 570 
time-generator comprises a dynamic series of functional brain states, which gate neuronal 571 
plasticity following daily experiences. The circadian clock, the reward system, and memory 572 
processes have many in common: light acts on all three systems through MAPK signalling 573 
pathway (Iyer, Wang, & Gillette, 2014) and all three are affected by the HPA-axes via 574 
cortisol, thereby leading to short-term changes (Albrecht, 2011; Eckel-Mahan et al., 2008). 575 
Moreover, most clock genes are expressed in brain areas that are associated with learning, 576 
memory, and reward (Albrecht, 2011), such as the amygdala (Lamont, Robinson, Stewart, & 577 
Amir, 2005), the hippocampus (Jilg et al., 2010; Wakamatsu et al., 2001) and the ventral 578 
tegmental area (Hampp et al., 2008).  579 
Conclusions  580 
ADHD is a common neuropsychiatric disorder affecting both wake and sleep phases 581 
of the diurnal cycle. Altered function of clock genes in ADHD is so far poorly understood, 582 
but mounting evidence suggests that atypical brain maturation and neurogenesis processes, 583 
sleep problems and the emergence of cognitive, executive functioning and self-regulation 584 
symptoms present in ADHD are at least partially subserved by circadian disruption (Charrier, 585 
Olliac, Roubertoux, & Tordjman, 2017; Kobayashi, Ye, & Hensch, 2015). Thus, on the one 586 
hand, studies showed that genetic risk factors exist, e.g., associations between ADHD and 587 
other neuro-developmental and psychiatric disorders and polymorphism (rs1801260) at the 588 
3′-untranslated region of the CLOCK gene, predispose to eveningness and sleep problems. 589 
On the other hand, the susceptibility of the circadian system to phase shift by timed BL 590 
exposure has broad cost-effective potential implications for the treatment of core symptoms 591 
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of ADHD as well as for augmentation for prevention of psychiatric comorbidities in ADHD. 592 
Moreover, for the non-responders to pharmacological treatment, introduction of LT protocols 593 
may be of outmost importance. Further studies are needed to evaluate therapeutic outcomes 594 
of different types of light therapy (blue-light emitting boxes vs. simulated dawn vs. natural 595 
daylight) and to explore causality between BL therapy and changes in circadian gene 596 
expression. A suitable model for studying circadian gene expression and molecular circadian 597 
function could be human skin fibroblasts. A recent study using BL therapy showed a poorer 598 
response to chronotherapy predicted by longer in vitro period in patients with N24SWD 599 
(Hida et al., 2017), suggesting that the period length is associated with chronotype and the 600 
fibroblasts rhythm correlates with circadian behaviour. Combined approach of assessment 601 
and phase shifting the circadian rhythm introduce new revenues for the integrated diagnosis, 602 
treatment and the evaluation of treatment of ADHD.  603 
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